Results 121 to 130 of about 12,783 (215)

The Role of Danavorexton for Perioperative Opioid-Induced Respiratory Depression and Sedation: A Narrative Review. [PDF]

Clin Pharmacol
Enache AJ, Harris CJ, Atewogbola TI, De Witt AB, Ahmadzadeh S, McGregor Jnr DW, Shekoohi S, Kaye AD.   +7 more
europepmc   +1 more source

Estimation of the Orexin Receptor Occupancy From Human Plasma Pharmacokinetics of Vornorexant, a Novel Dual Orexin 1/2 Receptor Antagonist for the Treatment of Insomnia. [PDF]

Pharmacol Res Perspect
Kamigaso S, Konno Y, Hikichi H, Kambe D, Mano Y, Tokumaru Y, Mori H, Yamasaki H, Chino Y, Hachiuma K, Mizuno-Yasuhira A.   +10 more
europepmc   +1 more source

Orexins: a new family of neuropeptides

British Journal of Anaesthesia, 1999
openaire   +2 more sources

Interoceptive Information of Physical Vigor Through Circulating Insulin-Like Growth Factor 1. [PDF]

FASEB Bioadv
Zegarra-Valdivia JA, Kahn MZ, Fernandes J, Suda K, de Sevilla MEF, Díaz-Pacheco S, Aleman IT.   +6 more
europepmc   +1 more source

Awakening Recovery: Enhancing Orexinergic Tone After Acute CNS Damage. [PDF]

Pharmaceuticals (Basel)
Otero-López P, Madrid-González X, Fernández-Dueñas V, Flores Á.   +3 more
europepmc   +1 more source

CO₂ Reactivity but Not CO₂-Induced Orexin/c-Fos Colocalization Differentially Predicts Alcohol-Seeking Behaviour After Extinction and Retrieval-Extinction in Rats. [PDF]

Addict Biol
Raskin M, Olvera M, Smith KA, Cofresí R, Shumake J, Telch MJ, Otto MW, Smits JAJ, Gonzales R, Lee HJ, Monfils MH.   +10 more
europepmc   +1 more source

Orexinergic pathway as a potential therapeutic candidate for the modulation of glucose homeostasis. [PDF]

Front Physiol
Hakizimana JC, Izabayo P, Izukwizabigenza Z, Alagbonsi AI.   +3 more
europepmc   +1 more source

Orexin Receptor Antagonism Improves Sleep Quality and Mitigates Lipopolysaccharide-Induced Inflammatory Responses in a Mouse Model. [PDF]

FASEB J
Horiuchi D, Irukayama-Tomobe Y, Kim JD, Kasuya Y, Nemoto T, Suzuki T, Nakagawa Y, Tatsumi K.   +7 more
europepmc   +1 more source

Central hypocretin/orexin administration alleviates sleep/wake disturbances, anhedonia, and neuroinflammation in an animal model of seasonal affective disorder. [PDF]

Ann Med
Costello A, Linning-Duffy K, Shi J, Lonstein JS, Yan L.   +4 more
europepmc   +1 more source

Association between skeletal fractures and sleep medication in patients with chronic kidney disease. [PDF]

BMC Nephrol
Onogi C, Watanabe Y, Tanaka A, Furuhashi K, Koshi-Ito E, Maruyama S.   +5 more
europepmc   +1 more source